Closing out today at the #ILCSymposium is LBCA Scientific Advisor Dr. Rachel Jankowitz moderating a session with our three funded #lobular #breastcancer researchers! ELBCC Lobular Breast Cancer IRL #LivingWithLobular LobularBCUK

International #lobular #breastcancer advocates meeting, greeting and getting to know each other at #ILCSymposium Utrecht! LobularBCUK Lobular Breast Cancer IRL #LivingWithLobular Lobular Breast Cancer Alliance ELBCC

Post-mortem tissue study promising to help understand #metastatic #lobular #breastcancer #bcsm KarenVanBaelen

New research out on early-stage #lobular #breastcancer. Older women (70+) may not need to have sentinel node biopsy. Thanks Dr. Steffi Oesterreich Adrian Lee et al for making sure #lobularBC is always included in research! #lobmob Leigh Pate Lobular Breast Cancer Alliance

Important poster presentation from LobularBCUK at #ILCSymposium exploring Delphi study results on improving care for patients with #lobular #breastcancer 👇👇👇👇 turns out lobular patients NEED tailored care and follow up #bcsm

Following quite a spectacular Patient Advocate led Session this morning we have an even more Spectacular Key Note Speaker #DAY2 Sabine Linn is now speaking 'Toward Precision Medicine for ILC' #ILCSymposium #Utrecht

Since we missed Leigh Pate from the #ILCSymposium Dr. Steffi Oesterreich read her message and she received a huge huge applause Lobular Breast Cancer Alliance

Impressive talk about ##ILC immune features, #Ecadherin #Pcadherin switching and #metastatic ILC #heterogeneity #clonal evolution Natrajan Lab ICR

George Sflomos Leigh Pate Dr. Steffi Oesterreich Lobular Breast Cancer Alliance Respect 🙌 and Gratitude 🙏 To #Lobmob Leader Leigh Pate from the entire attendance at The International Lobular Breast Cancer Symposium #ILCSymposium

Val Brunton from Edinburgh Cancer Research , one of our Scientific Advisor’s talking about the #lobular tumour microenvironment. #ILCSymposium

Such a great resource for patients with #lobular #breastcancer in 🔟 languages 🎉. Download and share 👇

LOVE IT! International #Lobular #breastcanceer Advocacy has launched and is flying! Onward!

👇👇👇👇👇👇👇👇👇👇👇👇👇👇👇👇

Amazing effort by #lobular #breastcancer #survivor flora migyanka 1.6 mil raised so far! 👇👇👇👇

Sounds like #ILCSymposium 2022 was a hit on all accounts! Thanks to all who worked so hard. Onward! 👇 Christine Desmedt Patrick WB Derksen Otto Metzger Dr. Steffi Oesterreich The Breast Cancer Research Foundation Anne Vincent-Salomon LobularBCUK Lobular Breast Cancer IRL #LivingWithLobular ELBCC Lobular Breast Cancer Alliance #bcsm

Nice write-up and #breastcancer #advocate Lori Petitti Lori Petitti Julia Katherine flora migyanka Double Whammy Dr. Steffi Oesterreich Matthew J. Sikora, PhD

🟡#breastcancer and the #PTEN hamartoma tumor syndrome (PHTS, previously #Cowden): screening with MRI led to the detection of cancer in 7 women/39 enrolled. All early-stage, all ductal (no #lobular). Median FU: 4 years. No benefit of adding mammography. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

Great video Lobular Breast Cancer Alliance. I have seen #lobular cancers missed on screening mammography be detected on MRI, CEM, MBI and US. Although access may be limited, supplemental screening for #ILC may be key, especially for those with #densebreast tissue. youtu.be/xNoXveXGC2g

Dear #cancer researchers ... How are you engaging w/ patients & patient advocates at your institutions? Are they a last minute box to be checked on your grant proposals? Or are they partners in your research? #PatientEngagement #PatientAdvocacyMovesScience 👇👇👇

Good things happen when research evals #lobular #breastcancer separately from #IDC. Meaningful for #metastatic #ILC patients #bcsm 👇 news-medical.net/news/20220623/…